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IN VITRO AND IN VIVO EVALUATION OF LOCALLY PRODUCED DENTAL 
PORCELAIN 
ABSTRACT 
Biocompatibility of dental porcelain is of crucial importance to the long-term 
success of dental prostheses because of· its close contact with oral tissues for 
extended periods. This study was designed to evaluate the biocompatibility of 
locally produced dental porcelain "test" using in vitro and in vivo methods. The in 
vitro cytotoxic potential of the test material was evaluated using test on extracts 
and direct contact test formats as per ISO 10993-5. Cell culture medium was used 
both as a control and an extractant. Additionally, a commercially available product 
was included to facilitate comparison of results. HOS cell line (ATCC, USA) was 
incubated for 72 hours with the extraction solutions of the test and commercial 
materials powders at various concentrations (50, 100, 150, 200 and 250 mg/ml). 
Similarly, MRC-5 cell line (ATCC, USA) was incubated for 72 hours with the test 
and commercial discs (5 mm in diameter and 2 mm thick). Aging process was 
carried out by submerging the discs into 3% Bovine Serum Albumin (BSA) solution 
for 96 hours followed by reincubation with the MRC-5 cell line. Cellular response 
was assessed using MTT [3-( 4,5-Dimethylthiazol-2-yl)-2 ,5-Diphenyltetrazolium 
Bromide] assay for measuring the mitochondrial succinate dehydrogenase (SDH) 
activity of living cells. Optical densities were measured at 570 nm using ELISA 
(Enzyme Linked lmmunosorbent Assay) reader and then converted to a 
percentage of the control for each cell culture well. Results were compared using 
one-way ANOVA and Tukey Post-Hoc comparisons at a significance level of P 
<0.05. For in vivo study, materials discs were implanted subcutaneously into 12 
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Sprague-Dawley male albino rats, which were sacrificed in groups of 3 at 1, 2, 3 
and 4 weeks after implantation. A semi-quantitative histological analysis of the 
tissue surrounding implanted discs was done under an image analyzer. In vitro 
cytotoxicity test on extracts showed that the test material was significantly different 
from the control at concentrations higher than 150 mg/ml. The mean(SD) 
percentage of cellular viability was 102.2(12.8) for 50 mg/ml, 98.9(10.3) for 100 
mg/ml, 89.4(15.8) for 150 mg/ml, 86.7(14.6) for 200 mg/ml and 82.9(16.5) for 250 
mg/ml. However, the commercial product was significantly different from the control 
at concentrations higher than 50 mg/ml. The mean(SD) percentage of cellular 
viability was 95.6(14.5) for 50 mg/ml, 85.4(12.4) for 100 mg/ml, 81.5(14.8) for 150 
mg/ml, 80.7(14.5) for 200 mg/ml and 79.3(10.9) for 250 mg/ml. Direct test showed 
that the materials after aging were not significantly different from the control. The 
mean(SD) percentage of cellular viability was 89.2(13.4) for the test and 89.4(14.6) 
for the commercial. The materials tested were already significantly different from 
the control before the conditioning of BSA. The mean(SD) percentage of cellular 
viability was 88.5(12.1) for the test and 88.5(8.9) for the commercial. However, in 
both tests, the materials caused mild suppression of SOH activity ( <25% of 
control), which is considered to be accepted clinically. In vivo subcutaneous 
implantation showed that the macrophage was clearly the dominant cell type at the 
implant surface at the first week after implantation, followed by a gradual decrease 
as the implantation period increased. On the contrary, fibroblasts and fibrocytes 
were the dominant cell types in the tissue surrounding test and commercial discs at 
the third and fourth week after implantation. These findings, from pathological point 
of view, might be an indicator of biocompatibility. 
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PENILAIAN PORSELIN PERGIGIAN PENGHASILAN TEMPATAN SECARA IN 
VITRO DAN IN VIVO 
ABSTRAK 
Biokompatibiliti porselin pergigian amat penting untuk kejayaan jangka panjang 
prostesis pergigian disebabkan persentuhan dengan tisu oral dalam jangka masa 
yang panjang. Kajian ini direka bentuk untuk menilai ujian biokompatibiliti porselin 
pergigian keluaran tempatan menggunakan kaedah in vitro dan in vivo. Bagi 
menilai potensi sitotoksik kaedah in vitro, bahan yang diuji dinilai menggunakan 
ujian ekstrak dan sentuh langsung mengikut format ISO 10993-5. Medium kultur 
sel ~igunakan sebagai kawalan dan ekstraktan. Satu porselin pergigian komersil 
digunakan untuk tujuan perbandingan. lnkubasi selama 72 jam dilakukan ke atas 
HOS sel line (ATCC, USA) menggunakan larutan ekstraksi daripada sebuk bahan 
ujian dan bahan komersil pada tahap kepekatan yang berbeza (50, 100, 150, 200 
and 250 mg/ml). MRC-5 selline juga diinkubasi selama 72 jam untuk bahan ujian 
dan bahan komersil dalam bentuk ceper (bergaris pusat 5 mm dan ketebalan 2 
mm ). Proses penuaan dijalankan dengan menenggelamkan ceper terse but ke 
dalam larutan 3% Serum Albumin Bovin (BSA) selama 96 jam dan proses inkubasi 
dilakukan semula dengan MRC-5 sel line. Reaksi sel dianalisa menggunakan MTT 
[3-(4,5-Dimetilthiazol-2-yi)-2,5-Bromide Difeniltetrazolium] assai bagi tujuan 
pengukuran aktiviti mitokondrial suksinat dehidrogenase (SOH) sel yang hidup. 
Ketumpatan beroptik diukur pada 570nm menggunakan bacaan ELISA (Enzyme 
Linked lmmunosoben assay) dan ditukar kepada peratusan kawalan bagi setiap 
"well" di dalam kultur sel. Hasil-hasil kajian dibanding menggunakan one-way 
ANOVA dan Tukey Post-Hoc pada tahap makna P <0.05. Untuk kajian in vivo, 
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bahan-bahan dalam bentuk ceper diimplankan di bawah lapisan kulit ke dalam 12 
ekor tikus jantan jenis albino Sprague Dawley. Tikus-tikus itu kemudiannnya 
dikorbankan dalam kumpulan bertiga pad a 1, 2, 3 dan 4 minggu selepas 
implantasi. Analisa histologi secara separa kuantitatif ke atas tisu sekeliling ceper 
dibuat menggunakan alat penganalisa imej. Bagi kepekatan melebihi 150mg/ml 
ujian sitotoksisiti secara in vitro ke atas ekstrak menunjukkan terdapat bebezaan 
yang nyata di antara bahan ujian dan bahan kawalan. Peratusan min(SD) sel hidup 
adalah 102.2(12.8) untuk 50 mg/ml, 98.9(10.3) untuk 100 mg/ml, 89.4(15.8) untuk 
150 mg/ml, 86.7(14.6) untuk 200 mg/ml dan 82.9(16.5) untuk 250 mg/ml. Walau 
bagaimanapun, produk komersil menunjukkan perbezaan yang nyata berbanding 
kawalan pada tahap kepekatan melebihi 50 mg/ml. Peratusan min(SD) sel hidup 
adalah 95.6(14.5) untuk 50 mg/ml, 85.4(12.4) untuk 100 mg/ml, 81.5(14.8) untuk 
150 mg/ml, 80.7(14.5) untuk 200 mg/ml dan 79.3(10.9) untuk 250 mg/ml. Ujian 
langsung menunjukkan tiada perbezaan yang nyata di antara bahan yang melalui 
proses penuaan dan bahan kawalan. Peratusan min(SD) bagi sel hidup adalah 
89.2(13.4) untuk bahan ujian dan 89.4(14.6) untuk bahan kawalan. Bahan yang 
telah diuji sememangnya berbeza dari kawalan sebelum dikondisikan dengan 
BSA. Peratusan min(SD) sel hidup adalah 88.5(12.1) untuk bahan ujian dan 
88.5(8.9) untuk bahan komersil. Namun begitu, dalam kedua-dua ujian, bahan 
yang digunakan telah menyebabkan penindasan secara ringan kepada aktiviti 
SDH (<25% bagi kawalan), suatu nilai yang boleh diterima pada tahap klinikal. 
Ujian in vivo menunjukkan dengan jelas bahawa macrophage adalah sel yang 
dominan pada permukaan ceper implan dalam minggu pertama implantasi, 
kemudian diikuti dengan penurunan yang sekata dengan peningkatan masa 
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implantasi. Sebaliknya, fibroblast dan fibrosit adalah sel yang dominan dalam tisu 
sekeliling ceper implan bahan ujian dan bahan komersil pada minggu ketiga dan 
keempat implantasi. Dari pandangan patologikal, keputusan ini menunjukkan 
kemungkinan terdapat biokompatabiliti. 
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CHAPTER ONE 
INTRODUCTION 
1.1 Background of the study 
CHAPTER ONE 
INTRODUCTION 
A ceramic is a compound formed by the union of metallic and non metallic 
elements. Most of these materials are oxides, formed by the union of oxygen with 
metals such as silicon, aluminum, calcium and magnesium (Ferracane, 2001 ). 
Porcelain is a specific type of ceramics, which has been widely used for nearly 
3,000 years; traditionally it is composed of blends of three naturally occurring 
minerals: pure white clay, quartz and feldspar. When these three ingredients are 
pulverized, blended, formed into shapes and baked, they compose of what is 
known as white-wares, so named because their colour is white after they are 
baked (Rosenblum and Schulman, 1997). Although many of the materials used in 
dentistry are ceramics, the term is commonly used to refer to porcelain and its 
derivatives. 
Because of its translucency, porcelain is considered to be the most natural-
looking restorative material for esthetic rehabilitation. It can be manufactured with 
such colours that are indistinguishable from the natural dentition. Furthermore, 
having an outer surface of metal oxides, porcelain does not permit the absorption 
of dental plaque byproducts, eliminating therefore the problem of surface colour 
changes, unlike composite resin (Veronese eta/., 2006). 
Porcelain differs from metals in that it contains ionic and/or covalent bonds. In 
contrast to metals, it is usually an electrical insulator because it has few electrons. 
It is very often transparent or translucent to light and is usually chemically very 
stable under a wide range of environmental conditions (Combe eta/., 1999). 
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Porcelain now plays a vital role in restorative dentistry. The demands of patients 
for tooth coloured restorations and the availability of new types of dental porcelain 
have increased its uses in a variety of restorative situations (Messer eta/., 2003). 
Common uses of porcelain include full coverage as crowns, inlays and onlays, 
porcelain bridges, veneering agents, castable ceramics and porcelain fused to 
metals restorations. Based upon some interesting technology, porcelain can also 
be cast into molds in the same way as conventional base metals or gold alloys 
(Leinfelder, 2000). 
However, porcelain is a brittle material and has low fracture resistance and 
relatively low flexural strength (Sundh et a/., 2005). The potential for abrading 
structures against which it occludes and the difficulty in resurfacing and polishing 
the glazed surface continue to be the biggest problem associated with this 
commonly used clinical material (Leinfelder, 2000). In addition, porcelain 
restorations require substantial reduction of the tooth to provide the bulk of material 
necessary for the translucency and optical properties associated with optimum 
esthetics. In all-ceramic restorations, the reduction is also necessary to provide the 
bulk of material required for adequate strength of the restoration. This requirement 
is also an undesirable side-effect of the material (Mackert, 1992). 
Today, in the development of an intraoral material, one must consider not only 
the strength, esthetics and functional aspects of the material but its biocompatibility 
as well. Since all materials used in medicine and dentistry interact with tissues, 
producing changes in both the material and the surrounding tissues (O'Brien, 
2002), preclinical assessments of the toxic potential of such materials or 
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components is needed to minimize the potential hazard to the patient. Thus, 
biocompatibility is important to manufacturers and materials scientists. 
1.2 Problem statement 
At no time in recent history has the interest in esthetics, biological safety and 
the relative cost and efficacy of dental care been greater than at the present time. 
As people retain their teeth for much longer time than in the past, the need for 
esthetically acceptable restorations is continuing to increase. 
In view of porcelain's desirable esthetic properties and biocompatibility, it is 
understandable that the demand for porcelain crowns has been increasing at the 
rate of 50% every 4 years (Noort, 2002). Therefore, porcelain will continue to be an 
important restorative material for many years to come. 
·However, porcelain restorations are currently expensive, primarily as a result of 
the labour-intensive nature of their fabrication. Porcelain crowns, bridges and 
veneers require a high degree of skills and several steps in their fabrication are 
critical to the success of these restorations. In addition, porcelain restorations 
require the exposure of patients to additional materials such as impression and 
temporary filling materials. 
Unfortunately, since there is no production of porcelain in Malaysia; the country 
has to import this material. Consequently, this leads to an increase in its price and 
subsequently the treatment cost as well. From this point of view, the School of 
Materials and Mineral Resources Engineering, Universiti Sains Malaysia (USM), 
Malaysia, decided to develop locally produced dental porcelain in order to minimize 
the import expense and therefore reduce the cost of dental treatment. 
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As for the current status of the locally produced dental porcelain, the School of 
Materials and Mineral Resources Engineering is working on the evaluation of its 
physical and mechanical properties, such as X-ray diffraction (XRD), X-ray 
fluorescence (XRF), scanning electron microscope (SEM), thermal expansion 
coefficients (TEC) and fire shrinkage. 
In fact, testing the biological effect of dental porcelain has lagged far behind the 
characterization of its mechanical and physical properties (Sjogren eta/., 2000 and 
Messer et a/., 2003). Most new porcelain materials have not been tested for 
biological response with the same scrutiny as has been applied to dental casting 
alloys (Wataha, 2002 and Schmalz and Garhammer, 2002), amalgams (Wataha et 
a/., 1994), or composites (Wataha et a/., 1999). Yet, the biocompatibility of 
porcelain is critical to the long-term success of dental prosthesis because porcelain 
restorations are in close contact with oral tissues for extended period. The issue 
has profound ethical, social, technical and legal effects on prosthodontic practice. 
1.3 Justification of the study 
The presence of proven biocompatible as well as durable locally produced 
dental porcelain, which can be provided to the patients in a cost-effective manner, 
may limit the import of the material, which in turn helps to reduce its cost and 
ultimately reduce the cost of dental treatment. 
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1.4 Objectives of study 
1.4.1 General objective 
To evaluate the biocompatibility of locally produced dental porcelain in order to 
improve the understanding of material characteristics and increase the ability to 
develop a more biocompatible product 
1.4.2 Specific objectives 
1.4.2.1 In vitro study 
1. To detect the potential ability of locally produced dental porcelain and a 
commercially available product in inducing toxic effects as observed at the cellular 
level 
2. To detect the potential cellular response changes to the materials tested 
following the exposure to a biological medium 
1.4.2.2 In vivo study 
To investigate cellular responses to locally produced dental porcelain and a 
commercially available product after a short-term subcutaneous implantation in a 
rat model 
1.5 Research hypothesis 
Locally produced dental porcelain is a satisfactory biocompatible material in 
terms of toxicity potential at the cellular level and short-term cellular responses to 
subcutaneous implantation in a rat model. 
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CHAPTER TWO 
LITERATURE REVIEW 
2.1 Biomaterials 
CHAPTER TWO 
LITERATURE REVIEW 
Biomaterials can be defined as any substances "other than a drug" or 
combinations of substances, synthetic or natural in origin, which can be used for 
any period of time, as a whole or as a part of a system, which treats, augments or 
replaces any tissue, organ or function of the body (von Recum and LaBerge, 
1995). 
Dentistry has a wider variety of biomaterials at their disposal than any other 
profession. Rigid polymers, elastomers, metals, alloys, ceramics, inorganic salts 
and composite materials are commonly encountered. 
2.2 Ceramics 
Ceramics have been widely used in biomedical applications for load bearing 
implants and the dental industry. Most members of this group are characterized by 
a high Young's modulus, very low elasticity and a hard and brittle surface 
(Suchanek and Yoshimura, 1998). 
2.2.1 Development of dental ceramics 
The word ceramic is derived from the Greek word "keramos", which literally 
means "burnt stutr' but which has come to mean more specifically a material 
produced by burning or firing. They are usually defined in terms of what they are 
not: nonmetallic "not metals" and inorganic "not resin". To distinguish them from 
rocks and minerals, the vast majority of which are also inorganic and nonmetallic, 
ceramics are additionally defined as man-made objects formed by baking row 
materials "minerals" at high temperatures (Rosenblum and Schulman, 1997). 
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Historically, three basic types of ceramic materials were developed. 
Earthenware, fired at high temperatures up to 900 °C, is relatively porous as the 
sintering process only just managed to fuse the particles of clay where they touch. 
This problem was overcome eventually by fusing a thin layer of a glassy material 
over the surface of the pot. This technology was used as far back as 5500 BC in 
various places. Stoneware, which appeared in China in about 100 BC, is fired at a 
higher temperature than earthenware, which results in both higher strength and 
also renders the material impervious to water. The third material is porcelain, 
obtained by fluxing white China clay with "China stone" to produce white 
translucent stoneware. This material was developed in China in about 1 000 AD and 
it was much stronger than the earthenware and stoneware. Translucent vessels 
could be produced with very thin walls of only 2 to 3 mm through which light could 
shine (Jones, 1985 and Noort, 2002). 
The early Chinese porcelain was called hard-paste porcelain. This hard paste 
product is often referred to as "true" porcelain and was highly translucent. The 
composition of traditional hard-paste porcelain is approximately 50% kaolin, known 
as china clay, (AI203Si022H20), 25% feldspar (K20AI20 36Si02) and 25% quartz 
(Si02). The first porcelains used in dentistry were originally based upon the triaxial 
porcelain composition, which falls into the zone of the K20-AI20 3-Si02 phase 
diagram (Jones, 1985). 
Although the earliest examples of porcelain are known to date back a 
thousands of years ago, the history of porcelain as a dental material only goes 
back just over 200 years (Ferracane, 2001 and Anusavice, 2003). 
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The first porcelain tooth material was patented in 1789 by a French dentist "de 
Chemant" in collaboration with a French pharmacist "Duchateau". The product, an 
improved version of "mineral paste teeth" that was produced in 177 4 by 
Duchateau, was introduced in England soon thereafter by de Chemant. However, 
this baked compound was not used to produce individual teeth because there was 
no effective way at that time to attach the teeth to a denture base material (Noort, 
2002 and Anusavice, 2003). 
In 1808, individually formed porcelain denture teeth that contained embedded 
platinum pins were introduced in Paris by Fonzi. Fonzi, an Italian dentist, called 
these teeth "terro-metalic" and their esthetic and mechanical versatility provided a 
major advance in prosthetic dentistry (Kelly eta/., 1996) . 
. Feldspathic porcelains have been first used to produce porcelain jacket crowns 
to dentistry ever since Charles Land (1903) described a technique for fabricating 
ceramic crowns using a platinum foil matrix and high-fusing feldspathic porcelain. 
Although these crowns are highly esthetic, their inability to withstand tensile and 
shear forces remains a major limitation (Moffa, 1988). 
Alumina ceramic Al20 3 has characteristics of high hardness and high abrasion 
resistance. The reasons for the excellent wear and friction behavior of Al20 3 are 
associated with the surface energy and surface smoothness of this ceramic. 
Abrasion resistance, strength and chemical inertness of alumina have made it to 
be recognized as a ceramic for dental and bone implants (Thamaraiselvi and 
Rajeswari, 2004). 
In the early 1950s, the ceramics employed in the conventional porcelain jacket 
crown were medium to high fusing feldspathic porcelains. Due to the relatively low 
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strength of this type of porcelain, an alumina-reinforced porcelain core material 
was developed by Mclean for the fabrication of porcelain jacket crowns. The 
alumina-reinforced crowns were regarded as providing better esthetics for anterior 
teeth than metal-ceramic crowns (Rizkallah and Jones, 2004). 
Aluminous core porcelain is a typical example of strengthening by dispersion of 
a crystalline phase. Alumina has a high modulus of elasticity and high fracture 
toughness. Its dispersion in a glassy matrix of similar thermal expansion coefficient 
leads to a significant strengthening of the core. The first alumina core porcelain 
provided by Mclean contained 40 to 50% alumina by weight. The core was baked 
on ~ platinum foil and later veneered with matched-expansion porcelain (Denry, 
1996). 
However, because of the large sintering shrinkage (approximately 15-25%) of 
the aluminous porcelain core material at its high firing temperature and the use of a 
20-25 }Cm thick platinum foil, excellent marginal adaptation was difficult to achieve 
except by highly skilled laboratory technicians. Therefore, the main indication for 
the use of aluminous porcelain crowns is the restoration of maxillary anterior 
crowns when aesthetic is of paramount importance and when no other ceramic 
product is available (Anusavice, 2003). 
Zirconia ceramics have several advantages over other ceramic materials. 
Compared with alumina, stabilized zirconia has the potential advantages of a lower 
elastic modulus, higher strength, better wear properties and higher fracture 
toughness (Eiiades eta/., 2003). 
The research on the use of zirconia (Zr02) as a biomaterial started about twenty 
years ago and it is now mainly used in the manufacturing of ball heads for total hip 
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replacements. However, developments are in progress for applications in other 
medical devices (Piconi and Maccauro, 1999). 
Porcelain fused to metal (metal-ceramic) technology was first described in 1956 
and patented in 1962. Alloys were produced with melting points sufficiently high to 
resist the firing of porcelain. The first alloys had a high noble metal content of 
around 98% with iron, indium and tin used for hardening and to create a superficial 
oxide layer to which the ceramic could be bonded (Wassell eta/., 2002). During 
this period, substantial improvements in alloys and veneering porcelains have 
resulted in widespread acceptance of metal-ceramic restorations. Continued 
research efforts have led to a more detailed and practical understanding of metal-
ceramic systems. 
·In 1997, adhesive metal-ceramic crown was introduced as an alternative to 
conventional crowns. The crown requires minimal preparation of the tooth and 
consists of a metal baking and porcelain labial surface. They are advocated for 
both anterior and posterior restorations and in the case of posterior restorations; 
the occlusal surface may be metallic to reduce abrasive damage to opposing teeth. 
Laboratory procedures involve lost wax casting and porcelain firing on refractory 
dies. The measurement of strength and durability of such restorations is suggested 
for further studies (Whitters eta/., 1999). 
Leucite-based frits, a potassium-aluminum-silicate phase, have been used 
since the early 1960s in metal-ceramic restorations because of the high coefficient 
of thermal expansion of leucite, which rises the bulk of porcelain thermal expansion 
to a level where it is compatible with the metal substrate. However, nowadays, 
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leucite is also used in all-ceramic restorations, not for thermal compatibility, but as 
a reinforcing material as it may act as a crack deflector (Cesar eta/., 2005). 
Although the porcelain fused to metal systems have high strength, the opacity 
of the metal substructure has encouraged the development of all-ceramic core 
materials containing crystalline components, which are stronger than the traditional 
"predominantly glassy amorphous" feldspathic porcelain. This type of core material 
can then be veneered with a more translucent ceramic material (Jones, 1998). 
The all-ceramic systems described by Jones ( 1998) are presented in table 2.1. 
2.2.2 Composition of traditional dental porcelain 
In the dental laboratory, traditional porcelain for dental restorations is used in 
fine powder form. Porcelain powder is manufactured from three primary 
crystalline ingredients are heated together with fluxes such as sodium carbonate or 
potassium carbonate. The fluxes cause the other raw ingredients to form a glass 
that is not crystalline and melts at a relatively low temperature compared with the 
row materials (Craig eta/., 2004). 
Feldspar is a range of natural crystalline minerals of aluminum, silicon and 
oxygen combined with smaller amounts of sodium, potassium and calcium. The 
presence of the alkalis controls the softening point of feldspar, which is lowered by 
increased sodium but increases with potassium content (Jones, 1998). 
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Table 2.1: All-ceramic systems used for producing crowns and inlays 
Type Description Process Examples 
Aluminous Dispersion Condensation of frit Vitadur 
core strengthening by high sintering, veneering and Hi-
porcelain modulus crystalline with a more translucent Ceram 
.. 
alumina particles in a feldspathic frit 
glass matrix 
Leucite Dispersion Pressure moulded frit IPS 
reinforced strengthening by sintered, veneering Empress 
porcelain crystalline leucite wjth translucent and Optec 
particles in a glass feldspathic frit 
matrix 
Slip-cast slurry in 
Glass porous mould sintered, In- Ceram 
infiltrated Highly filled crystalline infiltration by low Alumina 
alumina alumina in glass matrix viscosity glass, 
veneered with more 
translucent feldspathic 
frit 
Slip-cast slurry in 
Glass porous mould sintered, In- Ceram 
infiltrated Highly filled crystalline infiltration by low Spinel 
Spinel spinel in glass matrix viscosity glass, 
veneered with more 
translucent feldspathic 
frit 
Castable A glass which can be Cast using lost-wax Dicor 
glass crystallized by heat investment method 
treatment followed by heat-
treatment to precipitate 
a crystalline phase 
Glass A glass ceramic Milling (mostly inlays) Dicor, 
Ceramic machinable material by computer control MGCand 
CAD-CAM Vita bloc 
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In dental feldspathic porcelain, feldspar makes up 75 to 85% of the porcelain 
and serves as the amorphous and glassy phase that holds the silica mineral 
crystals together. Kaolin clay (aluminum silicate), added at only 3 to 5%, serves as 
an opaquing agent and enhances the workability of porcelain. In contrast to dental 
porcelains, decorative porcelain contains high concentrations of kaolin and low 
concentrations of feldspar (Ferracane, 2001 ). 
Some contemporary feldspathic materials are reinforced by the presence of up 
to 45% of leucite, which has the formula KA1Si20 6. In terms of coefficient of the 
thermal expansion, there is a considerable mismatch between that of leucite (22 
parts per million per °C) and the glassy phase (8 parts per million per °C). On 
cooling, there are resultant compressive stresses in the glass around the leucite 
particles. Such stresses act as crack deflectors, resulting in a material with greater 
modulus of rupture (Combe eta/., 1999). 
However, only a lower leucite contents "from zero to 20%" has a strengthen 
effect on the material, as the residual stresses arise from the addition of high 
quantities of leucite "from 30 to 50%" may cause spontaneous microcracking within 
the material during cooling, which leads to a significant reduction in the strength 
values of the porcelain (Cesar eta/., 2005). 
The recent introduction of the pressed leucite reinforced ceramic system, IPS 
Empress, has leucite in a different role. This material relies on an increased 
volume of fine leucite particles to increase flexural strength. Similar versions using 
finely dispersed leucite grains to increase toughness, strength and modify wear 
patterns and rates to make them similar to enamel wear rates are now available for 
metal-ceramic restorations (Ironside and Swain, 1998). 
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To allow the fabrication of porcelain restorations in tooth colours, small 
quantities of colouring agents are added to porcelain powders. These pigments 
"also called colour frits" are derived from metallic oxides that are ground and mixed 
with feldspar powder; this mixture is then fired and fused to a glass and the 
pigmented glass is then reground to powder. Commonly used oxides include tin 
oxide for opaquing, iron oxide for brown shading, copper oxide for blue, nickel 
oxide for brown and manganese oxide for purple (Nathanson eta/., 1999). 
Some feldspathic porcelains are supplied as "opalescent porcelains". 
Opalescence is a light scattering effect achieved by the addition of very small 
amounts of metallic oxides having a higher refractive index and a particle size near 
to that of the wave-length of light. Since natural teeth can display some 
· opalescence, the availability of opalescent porcelains adds further to the ability to 
match natural tooth appearance in every way (McCabe and Walls, 1998). 
2.2.3 Classifications of dental porcelain 
The porcelain powder is mixed with water to form slurry, which is adapted as a 
plastic mass to the requisite shape prior to firing in an oven. According to a 
standard specification, the available materials may be classified according to their 
temperature of fusion in the dental laboratory as follows (O'Brien, 2002). 
• High fusing: 1 ,288 °C to 1 ,371 °C - (2,350 °F to 2,500 °F) 
• Medium fusing: 1,093 °C to 1,260 °C- (2,000 °F to 2,300 °F) 
• Low fusing: 660 °C to 1 ,066 °C - ( 1 ,220 °F to 1 ,950 °F) 
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Classification can also be made according to application (Combe and Grant, 1992). 
• Core porcelain, which is the basis of porcelain jacket crowns and characterized 
by high mechanical properties. 
• Dentine or body porcelain, which is more translucent than the above and largely 
governs the shape and colour of restorations. 
• Enamel porcelain, which is used in areas requiring maximum translucency, for 
example, at the incisal edge. 
2.3 Biocompatibility of biomaterials 
Biomaterials and medical devices constitute an extremely diverse and 
heterogeneous category of items. Because the use of these products normally 
entails their direct or indirect contact with patients, there is an obligation on the part 
of manufacturers to establish the safety of their products before they are marketed. 
Medical device safety evaluation assesses the risk of adverse health effects due to 
normal use and likely misuse of a device. Adverse health effects could result from 
the exposure to the materials from which a device is made. Therefore, biological 
evaluation such materials or components is needed (Bollen and Svendsen, 1997). 
2.3.1 Definition of biocompatibility 
The term biocompatibility is defined as the ability of a material to elicit an 
appropriate biological response in a given application (Williams, 1987). If examined 
closely, the definition of biocompatibility implies an interaction among a host, a 
material and an expected function of the material (fig. 2.1 ). Biocompatibility exists 
only when all 3 factors are considered and it can change if any of these factors 
change (Wataha, 2001 ). 
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In practice, however, no material is totally inert in a biological environment. 
Thus, an appropriate host response, which may be a complex series of events, is 
important. Furthermore, a material may degrade in situ, so biocompatibility of its 
degradation products also needs to be noted (Combe eta/., 1999). 
Biocompatibility 
Patient 
Material 
Function 
Material 
Fig. 2.1: Interactions between host, material and application of material 
2.3.2 Assessment of biocompatibility 
Measuring the biocompatibility of a material is not simple and the methods of 
measurement are evolving rapidly as more is known about the interactions 
between dental materials and oral tissues and as technologies for testing improve. 
Traditionally, there are three basic types of tests used to measure the 
biocompatibility of dental materials: the in vitro tests, the animal tests and the 
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usage tests performed either in animals or in humans (Schmalz, 1997). Each of 
these tests has advantages and disadvantages and each is used to some extent to 
evaluate a material before it is made available commercially. 
2.3.2.1 Primary (in vitro) tests 
The major category of tests for the initial evaluation of materials is the 
cytotoxicity test. From the earliest periods of cell culture, there has been an 
emphasis on establishing standards by gathering data, which could be validated 
among several labs in the same way that material properties could be validated by 
chemical and physical testing and understanding of the general nature of the 
reactions, which take place in response to materials, usually via direct contact. The 
use of in vitro techniques to study the toxicity of various synthetic materials began 
some 30 years after tissue culture was first established. Various investigators 
began to apply organ and tissue culture techniques to toxicological problems in the 
1950s and 1960s (Hanks eta/., 1996). 
A critical term in the evaluation of biomaterials biocompatibility is toxicity. A toxic 
material is defined as something that releases a chemical in a quantity sufficient to 
kill cells directly or indirectly by inhibiting important metabolic pathways. A cytotoxic 
material is a term used to define an agent that is "cell killing". The percentage of 
cell death is an indication of the potency "dose" of the agent. Although several 
factors may contribute to the toxicity of a chemical, the dose of the agent delivered 
to the cell is the most important factor (Guelcher and Hollinger, 2005). 
Cell culture studies are useful tools for dental materials investigations. Cell 
culture methods are better standardized and reproducible. They are rapid and easy 
to perform at relatively low costs (Schmalz, 1994). 
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The tests of the row materials and formulation must be repetitive and 
consistent. For ethical and legal reasons, in vitro toxicity assessments have been 
proposed as an alternative approach to animal use (Verhulst et a/., 1998). Animal 
models are essential in providing information on biological reactions to biomaterials 
but their results are difficult to interpret . at the cellular level because of the 
numerous and complex events that occur at the insertion of a foreign material into 
a bloody wound site. In vitro approaches, however, represent ideal systems for 
studying cell behavior with materials, thus avoiding the complications and 
interferences encountered in vivo (Josset eta/., 1999). 
The common conception of cytotoxicity is that the cell is killed by the cytotoxin. 
Cytotoxins may have reversible or irreversible effects and their effects may be 
immediate or delayed up to several weeks. There are major differences between 
( 1) physico-chemical damage, which may produce an instantaneous loss of 
viability, (2) an environmental or pharmaceutical cytotoxin, which may have a slight 
but progressive effect on metabolism over a period of hours or longer and (3) a 
loss of reproductive potential, e.g. as a result of irradiation, which may not be 
immediately apparent in the reduction of cellular viability (Stacey eta/., 2001 ). 
The high sensitivity of cytotoxicity tests is due to the isolation of the test cells in 
cultures and the absence of the protective mechanisms that assist cells within the 
body. Results of these tests correlate reasonably well with short-term implant 
studies. However, they do not necessarily correlate with other standard tests of 
biocompatibility that are designed to examine specific end points (such as 
sensitization) or that use extracts prepared under more rigorous conditions (for 
example, at 121°C in saline) (Wallin and Arscott, 1998). 
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2.3.2.1.1 Cellular functions evaluation 
By using cell cultures, the changes of some cellular functions induced by 
artificial materials or devices are evaluated as described in table 2.2 by Cenni et a/. 
( 1999). In the screening stage, the functions shared by all types of cells are 
investigated. In the supplementary tests, specific functions are studied; the cells of 
the same type that will face the implant in vivo are used whenever possible (Cenni 
eta/., 1999). 
Table 2.2: Functions common to all cells and evaluation methods 
Function Tests 
Enzyme 
- Reduction of tetrazolium salts (MTT test) activity 
- Oxide reduction activity (Aiamar blue assay) 
Cellular 
- Neutral red uptake 
viability 
- Propidium iodide staining 
Cellular 
-Cell count growth 
- Crystal violet or amidoblack staining 
- Total protein assay 
-DNA assay 
-
3H-TOR uptake 
2.3.2.2 Secondary (animal) tests 
The obviousness that animals are the key to in vivo testing is of striking 
importance and readily acknowledged by the community of individuals involved in 
biomaterial testing. Each animal toxicity test measures one of the many aspects of 
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toxicity, such as acute and chronic systemic toxicity, local irritancy to the skin and 
eye, teratogenicity, etc (Georgieva, 2003). 
Sensitization or hypersensitivity tests are indicated to detect materials, which 
are capable of interacting with the body's immune system and inducing specific 
hypersensitivity, such that, on subsequent exposure to the same material 
characteristic, allergic effects are produced. They are used by exposing the skin to 
the material or taking extracts from the device or materials and injecting or topically 
applying them to the animal (ISO 10993-10, 1992). 
Irritation tests evaluate the reaction to a single, repeated or continuous 
exposure of materials that may produce skin, mucosal or eye irritation as a 
localized non-specific tissue response characterized by the usual signs of 
inflammations. These tests do not involve the immunological mechanism in the 
body (ISO 10993-10, 1992). 
Systemic toxicity tests evaluate the potential adverse effects of medical devices 
on the body's organs and tissues that are remote from the site of contact. 
Depending on the type of device being tested, topical, inhalation, intravenous, intra 
peritoneal or oral administration of extracts or implantation of the device in the 
animal is observed for toxicity. There are four categories of toxicity evaluations, 
which include acute (24 hours), subacute (14 to 28 days), subchronic (90 days or 
10% of the animal life span) and chronic (ISO 10993-11, 1993). 
Implantation tests are the most direct means of evaluating the potential effects 
of materials on the surrounding living tissue. Samples are cut to size, if necessary; 
sterilized and implanted aseptically inside the body of a laboratory animal. After a 
period of time ranging from weeks to months, the implant sites are examined. 
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Attention is focussed entirely on local effects that occur in response to the 
presence of the test material that has been in intimate contact with living tissue. 
Part six of the biocompatibility standards developed by the International 
Organization for Standardization, ISO 10093-6, presents the general 
considerations that must be taken into account when conducting such implant 
studies. It describes the selection of species, appropriate tissues for implantation, 
the length of time implants should remain in place, implantation methods and the 
evaluation of biological responses (ISO 10993-6, 1994). 
The tissue and cellular response to biomaterials implanted in animals is 
screened on the basis of morphological observations on routine histological 
evaluation. This investigation takes into account the type of cells present and their 
populations (Butler eta/., 2001 ). 
Experiments on animals are very useful and entirely conclusive for the 
toxicology and hygiene of humans. On this view, the primary function of animal 
tests is to uncover the casual mechanisms, which produce and direct the course of 
a disease or condition in animals. These results are then extended by analogy to 
humans. The resultant understanding of the relevant casual mechanisms in 
humans empowers scientists to prevent or treat the disease or condition under 
investigation (LaFollette and Shanks, 1995). 
2.3.2.3 Usage tests 
Usage tests are performed in animals or in human volunteers. They are distinct 
from other animal tests because they require that the material be placed in a 
situation identical to its intended clinical use. The relevance of a usage test to 
clinical practice is potentially high by definition. However, these tests are extremely 
21 
expensive, last for long periods and are exceptionally difficult to control and 
interpret accurately. Finally, human usage tests may involve many legal liabilities 
and issues that are not factors for animal and in vitro tests (Craig and Powers, 
2002 and Anusavice, 2003). 
2.3.3 Screening concepts for measuring biocompatibility 
For approximately 20 years, researchers have recognized that the most 
efficient, cost-effective and relevant way to evaluate the biocompatibility of 
materials is to use a combination of in vitro, animal and usage tests (Schmalz, 
1996). However, the ways in which these tests are used together and philosophies 
about the role of each type of test have changed somewhat over the years 
(Schmalz, 1997). 
· Schmalz (1997), Wataha (2001) and Craig and Powers (2002) proposed a 
pyramid scheme of unspecific toxicity tests followed by specific toxicity tests and 
then clinical trials (fig. 2.2, a). Only materials that passed level 1 were tested 
further. Unspecific tests were not directly relevant to use of material. Approximately 
10 years later, other pyramid scheme were proposed and divided the pyramid into 
primary, secondary and usage tests and is still commonly used today (fig. 2.2, b). It 
differed from the previous scheme because the former emphasizes many cellular 
reactions in addition to toxicity. As in scheme "a", each test level screens for tests 
above it. Primary tests measure basic biological properties such as toxicity or 
mutagenicity of material. Secondary tests assess more advanced properties such 
as allergenicity. Usage tests are equivalent to the clinical trial. Newer schemes 
have been developed that reflect the complexity of biocompatibility testing of 
materials (fig. 2.2, c and d). The newer schemes recognize the need to use several 
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types of tests together and treat evaluation of materials biocompatibility as an 
ongoing process. 
a 
c 
. Progress 
of 
Specific Toxicity 
Unspecific Toxicity 
Usage 
Progress 
of 
Testing 
Secondary 
Primary 
Secondary 
Primary 
Usage 
d 
Primary 
Fig. 2.2: Schemes for testing biocompatibility 
2.3.4 Issues in ceramics biocompatibility 
2.3.4.1 In vitro studies 
Progress 
of 
Testing 
Secondary 
Ozen et a/. (2005) conducted a study to determine the influence of various 
types of dental casting alloys and all-ceramic (ln-Ceram) materials on cellular 
viability and the cytokine 1L-1beta (B) secretion level in a three-dimensional cell 
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culture system consisting of human gingival fibroblast cells. Cellular viability was 
measured by colorimetric tetrazolium (MTT) reduction test and for 1 L-1 (11) 
measurement, assay aliquots were taken from exposed media after different 
exposure times. According to their investigation on ceramic, the authors reported 
that the material did not influence cellular viability. Moreover, it did not elevate 1 L-
1 (11) release from cells at non-toxic levels. The study finding suggests that the 
cytotoxicity level of the ceramic material tested is in parallel to their 1L-1(11) level. 
This finding indicates that the material may not be involved in inflammatory 
activities at non-toxic levels. The authors recommended the use of 1L-1(11) 
parameters, as they provide a better result than a single end point about the 
biological response of the test materials. 
Lin et a/. (2005) studied the in vitro biocompatibility of calcium silicate (CaSi03) 
ceramics by examining the adhesion and proliferation of the bone marrow 
mesenchymal stem cells. The result showed that the ceramics studied supported 
cells adhesion and proliferation, which indicated good biocompatibility. The authors 
suggest that CaSi03 ceramics might be a potential bioactive material as bone 
implants. 
Ryu et a/. (2004) conducted a qualitative evaluation of the cytotoxic effects of 
MgO-doped HA I 11-TCP ceramics using murine fibroblast L929 cells. Phosphate 
Buffered Saline was used as an extractant and Dulbecco's Modified Eagle Medium 
supplemented with 1 0% fetal bovine serum as a negative control. The in vitro result 
showed that L929 cells grew well in the extract of 1 wt% MgO-doped HA/11-TCP 
ceramics. As compared with the negative control, morphological changes and 
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